Breakthrough gene therapy jab reverses hearing loss in weeks
The cutting-edge therapy improved hearing in children and adults with congenital deafness or severe hearing impairment, with a 7-year-old regaining almost full hearing in a clinical trial, researchers from Sweden 's Karolinska Institutet said.
The clinical trial, detailed in the journal Nature Medicine, showed that a healthy copy of the OTOF gene injected in the inner ear improved hearing of all 10 participants.
The small-scale trial included people who had a genetic form of deafness or severe hearing impairment caused by mutations in a gene called OTOF.
These mutations cause a deficiency of the protein otoferlin, which plays a key role in transmitting sound signals from the ear to the brain.
While the therapy seemed to work best in children, researchers said, it could benefit adults as well.
In the trial, a synthetic, harmless version of the adeno-associated virus was used to deliver a properly functional OTOF gene to the inner ear via a single injection.
The effects of the therapy were evident in the majority of patients, whose hearing recovered rapidly after just a month.
After six months, researchers noted considerable hearing improvement in all participants, with their average volume of perceptible sound improving from 106 decibels to 52.
Those between the ages of five and eight responded best to the treatment, the study found.
One seven-year-old girl quickly recovered almost all her hearing, and she was able to hold daily conversations with her mother four months afterwards.
'This is the first time that the method has been tested in teenagers and adults,' Maoli Duan, an author of the study from Karolinska Institutet, said.
"Hearing was greatly improved in many of the participants, which can have a profound effect on their life quality. We will now be following these patients to see how lasting the effect is.'
Researchers also found that the treatment was safe and well-tolerated. Participants did not report any serious adverse reactions in the follow-up period of 6-12 months.
The most common reaction was a reduction in the number of the immune system's neutrophils, a type of white blood cell.
"OTOF is just the beginning," Dr Duan said, adding that researchers were working on other common genes behind deafness such as GJB2 and TMC1.
'These are more complicated to treat, but animal studies have so far returned promising results. We are confident that patients with different kinds of genetic deafness will one day be able to receive treatment.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
2 hours ago
- Daily Mail
AstraZeneca boost as EU approves cancer drug
An AstraZeneca cancer drug received the green light by European regulators yesterday. The London-listed drugs maker revealed that its bladder cancer treatment Imfinzi has been approved to treat adult patients in the European Union. It comes amid reports that AstraZeneca – the FTSE 100's largest company – is considering moving its listing from the UK to the US in what would be a hammer blow to London's stock market. The speculation was fuelled by the pharmaceutical sector's growing frustration with the UK's rules on approving medicines as well as a row over drug prices between the industry and the NHS. Dave Fredrickson, head of AstraZeneca's oncology haematology unit, said: 'Imfinzi is poised to transform the standard of care for muscle-invasive bladder cancer in Europe.' AstraZeneca shares edged up 1.3 per cent yesterday.
The Sun
2 hours ago
- The Sun
Fat jabs are ruining dinner parties as guests on weight-loss drugs lose appetites and offend their hosts
FAT jabs are ruining dinner parties as guests on weight-loss drugs lose their appetites. A survey found one in three hosts have been annoyed by invitees rejecting meals they prepared. 2 2 Eighty per cent on the injections say they now find the social side of eating and drinking uncomfortable. Nearly half feel it has ruined their enjoyment of dinner parties completely — with 29 per cent of hosts getting upset. Ten per cent of guests have even stashed food in a napkin to hide their embarrassment. Jon Horsley, from trends and insights agency Perspectus Global, said: ' Weight-loss drugs are still in their early days. 'The fact that their use can make social eating difficult is just one unforeseen effect.' And it is not just food that is spoiled for those on jabs like Ozempic and Mounjaro, as 18 per cent say they can no longer enjoy wine or cocktails. Sixty per cent believe the correct etiquette is to let hosts know ahead of time that guests are on the jabs, so menus can be adjusted accordingly. Perspectus Global's survey of 2,000 guests and hosts found lighter options such as prawn cocktail, melon and prosciutto, fish soup or a small fillet steak are the most suitable options. For dessert, a sorbet is the order of the day. Mr Horsley added: 'Shared meals may become more awkward until we work past the social difficulties, adapt our menus and the etiquette surrounding the subject.'
Medical News Today
4 hours ago
- Medical News Today
Could a single brain scan predict the risk of age-related conditions like dementia?
People age at different rates, partly due to genetics but largely because of lifestyle.A person's rate of aging can indicate how likely they are to develop age-related disorders, such as researchers have developed a method based on a single brain scan in middle age that could predict how fast a person is likely to suggest that their method, which can predict the aging rate of both brain and body, may detect who should implement lifestyle changes to reduce their risk of age-related people appear to age more slowly than others. This is partly due to genetics, which studies suggest accounts for around 25% of the variation in longevity but is largely due to lifestyle and the in lifestyle, such as following a healthy diet, exercising regularly, getting adequate sleep, not smoking, and not drinking alcohol to excess, can help slow a person's rate of aging and delay or prevent age-related disorders.A person's rate of aging is often referred to as their biological age — how old their cells are — which can vary greatly from their chronological age, or the number of years since their birth. Measuring this can be a group of researchers from Duke, Harvard, and the University of Otago, New Zealand, have developed a method of predicting how fast a person will age, based on a single brain scan performed around the age of 45. In their study, which is published in Nature Aging, the researchers suggest that the Dunedin Pace of Aging Calculated from NeuroImaging (DunedinPACNI) could help researchers determine how aging affects health, and help them evaluate the effectiveness of anti-aging strategies.'The study developed and validated a new MRI-based biomarker called DunedinPACNI which shows not only a score for brain age, i.e. how old the brain looks, but also shows connections to cognitive decline and other health measures, allowing to perhaps predict how quickly a person ages and how their health will evolve later in life,' Madalina Tivarus, PhD, associate professor of Imaging Sciences and Neuroscience at the Del Monte Institute for Neuroscience at the University of Rochester, not involved in the study, told Medical News scan can predict biological aging'The idea of using a routine MRI brain scan to do a 'aging check-up' is very interesting and exciting,' Tivarus told study builds on the Dunedin Study, previous research conducted in the same cohort of participants. This study, which followed a group of 1,037 people born in Dunedin, New Zealand in 1972–'73, looked at age-related changes in gene methylation to create an epigenetic the Dunedin Study, researchers regularly tested participants' blood pressure, body mass index (BMI), glucose (blood sugar) and cholesterol levels, lung and kidney function, and even gum recession and tooth almost 20 years, they used the overall pattern of change across these health markers to generate a score for how fast each person was the latest study, researchers used a single MRI scan of the brain performed when participants were aged 45, which they correlated with the Dunedin Study aging data. They then developed their DunedinPACNI to estimate rate of aging using only information from the MRI evaluate the Dunedin PACNI as a tool for predicting age-related health outcomes, they analyzed it against datasets from the Alzheimer's Disease Neuroimaging Initiative (ADNI), UK Biobank, and Latin American Brain Health found that their prediction accuracy was in line with more established epigenetic with faster DunedinPACNI scores had several indicators of more rapid aging, including:worse balance, slower gait, weaker lower and upper body strength, and poorer coordinationself-reported worse health and more physical limitations poorer performance on cognitive function tests greater childhood-to-adulthood cognitive declineolder physical MacSweeney, MD, CEO and consultant Neuroradiologist at Re:Cognition Health, who was not involved in this research, highlighted how important brain imaging could be, telling MNT that:'The researchers observed that individuals with higher DunedinPACNI scores, indicating faster brain aging, were also more likely to experience health deterioration in other organ systems, such as cardiovascular and respiratory health. The fact that brain imaging can reflect systemic aging suggests the brain may serve as a biomarker for overall biological age, offering a non-invasive, accessible measure of aging processes throughout the body.'Novel brain scan better predictive tool than existing MRI measuresTivarus enthused that:'This study is exciting because it shows that MRI scans might be used not just to detect disease, but also to track how the brain is aging long before problems begin. However, it's still early days. While promising, DunedinPACNI still needs to be tested more widely in larger and more diverse populations across different ages, ethnicities, and health backgrounds. It did perform well across multiple large datasets, but more global validation is needed.'The researchers compared the DunedinPACNI with measures of hippocampal and ventricular volume, which are commonly used MRI-based measures of brain aging, using UK Biobank and ADNI found that faster DunedinPACNI was more consistently and strongly associated with poor cognition, poor health, frailty, and risk of dementia, disease and mortality than either of these was impressed by the study structure.'The study methodology has some important strengths such as it is using a robust, decades-long longitudinal dataset, uses sound statistical methods, and has been validated extensively using imaging data from other large studies,' she she also pointed out that there were 'some limitations, such as the specific population data used to train the model (mostly European ancestry, from a specific geographical location), its performance in younger or pediatric populations is untested, [and] it infers dynamic processes from one static image (one MRI snapshot).' 'While I don't think it is ready for clinical use, DunedinPACNI appears to be a promising imaging biomarker of biological aging,' Tivarus told us.'The tool empowers people to take proactive steps'As people are living longer, but not necessarily healthier, lives, the ability to predict who is more likely to develop dementia or other age-related illness is becoming increasingly important. The researchers hope that their tool might eventually help clinicians do that well before symptoms, allowing interventions to reduce the risk of conditions developing.'Identifying accelerated aging in midlife provides a critical window of opportunity for intervention. Knowing one's biological age, as distinct from chronological age, could motivate individuals to adopt healthier habits, such as improved diet, increased physical activity or better sleep. By highlighting risk decades in advance, the tool empowers people to take proactive steps that may slow or even reverse aspects of biological aging.' – Emer MacSweeney, MD
